Oran, B <br/><br/>
Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation.  [electronic resource] 

 -  Leukemia  Dec 2007 
 - 2540-4 p.  digital 
<br/><br/> Publication Type: Comparative Study; Letter 
<br/><br/><label>ISSN: </label>1476-5551 
<br/><br/><label>Standard No.: </label>10.1038/sj.leu.2404828  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Combined Modality Therapy<br/>Female<br/>Hematopoietic Stem Cell Transplantation--statistics & numerical data<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Lymphocyte Transfusion--statistics & numerical data<br/>Male<br/>Middle Aged<br/>Myeloablative Agonists--administration & dosage<br/>Myelodysplastic Syndromes--drug therapy<br/>Palliative Care<br/>Recurrence<br/>Remission Induction<br/>Salvage Therapy<br/>Transplantation Conditioning--methods<br/>Transplantation, Homologous